Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study

Chin Med J (Engl). 2022 Sep 5;135(17):2134-2136. doi: 10.1097/CM9.0000000000002243.

Authors

Yun Tang¹, Xiaobo Yang, Huaqing Shu, Yuan Yu, Jiqian Xu, Shangwen Pan, Xiaojing Zou, Shiying Yuan, You Shang

Affiliation

¹ Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.

No abstract available

Publication types

Clinical Trial, Phase I
Letter

MeSH terms

Benzodiazepines*
Humans
Hypnotics and Sedatives / therapeutic use
Intensive Care Units
Midazolam*

Substances

Benzodiazepines
Hypnotics and Sedatives
Midazolam
remimazolam